Robert P Thomen1, Ajay Sheshadri, James D Quirk, Jim Kozlowski, Henry D Ellison, Rhonda D Szczesniak, Mario Castro, Jason C Woods. 1. From the Department of Physics, Washington University in St Louis, St Louis, Mo (R.P.T., H.D.E., J.C.W.); Department of Internal Medicine (A.S., J.K., M.C.) and Mallinckrodt Institute of Radiology (J.D.Q.), Washington University School of Medicine, St Louis, Mo; and Center for Pulmonary Imaging Research (R.P.T., J.C.W.) and Division of Biostatistics and Epidemiology (R.D.S.), Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229.
Abstract
PURPOSE: To quantify regional lung ventilation in healthy volunteers and patients with severe asthma (both before and after thermoplasty) by using a combination of helium 3 ((3)He) magnetic resonance (MR) imaging and computed tomography (CT), with the intention of developing more effective image-guided treatments for obstructive lung diseases. MATERIALS AND METHODS: With approval of the local institutional review board, informed consent, and an Investigational New Drug Exemption, six healthy volunteers and 10 patients with severe asthma were imaged in compliance with HIPAA regulations by using both multidetector CT and (3)He MR imaging. Individual bronchopulmonary segments were labeled voxel by voxel from the CT images and then registered to the (3)He MR images by using custom software. The (3)He signal intensity was then analyzed by evaluating the volume-weighted fraction of total-lung signal intensity present in each segment (segmental ventilation percentage [ SVP segmental ventilation percentage ]) and by identifying the whole-lung defect percentage and the segmental defect percentage. Of the 10 patients with asthma, seven received treatment with bronchial thermoplasty and were imaged with (3)He MR a second time. Changes in segmental defect percentages and whole-lung defect percentages are presented. RESULTS: Ventilation measures for healthy volunteers yielded smaller segment-to-segment variation (mean SVP segmental ventilation percentage , 100% ± 18 [standard deviation]) than did the measures for patients with severe asthma (mean SVP segmental ventilation percentage , 97% ± 23). Patients with asthma also demonstrated larger segmental defect percentages (median, 13.5%; interquartile range, 8.9%-17.8%) than healthy volunteers (median, 6%; interquartile range, 5.6%-6.3%). These quantitative results confirm what is visually observed on the (3)He images. A Spearman correlation of r = -0.82 was found between the change in whole-lung defect percentage and the number of days between final treatment and second (3)He imaging. CONCLUSION: Regional quantification of lung ventilation is indeed feasible and may be a useful technique for image-guided treatment of obstructive lung diseases, such as bronchial thermoplasty for severe asthma. In these patients, ventilation defects decreased as a function of time after treatment.
PURPOSE: To quantify regional lung ventilation in healthy volunteers and patients with severe asthma (both before and after thermoplasty) by using a combination of helium 3 ((3)He) magnetic resonance (MR) imaging and computed tomography (CT), with the intention of developing more effective image-guided treatments for obstructive lung diseases. MATERIALS AND METHODS: With approval of the local institutional review board, informed consent, and an Investigational New Drug Exemption, six healthy volunteers and 10 patients with severe asthma were imaged in compliance with HIPAA regulations by using both multidetector CT and (3)He MR imaging. Individual bronchopulmonary segments were labeled voxel by voxel from the CT images and then registered to the (3)He MR images by using custom software. The (3)He signal intensity was then analyzed by evaluating the volume-weighted fraction of total-lung signal intensity present in each segment (segmental ventilation percentage [ SVP segmental ventilation percentage ]) and by identifying the whole-lung defect percentage and the segmental defect percentage. Of the 10 patients with asthma, seven received treatment with bronchial thermoplasty and were imaged with (3)He MR a second time. Changes in segmental defect percentages and whole-lung defect percentages are presented. RESULTS: Ventilation measures for healthy volunteers yielded smaller segment-to-segment variation (mean SVP segmental ventilation percentage , 100% ± 18 [standard deviation]) than did the measures for patients with severe asthma (mean SVP segmental ventilation percentage , 97% ± 23). Patients with asthma also demonstrated larger segmental defect percentages (median, 13.5%; interquartile range, 8.9%-17.8%) than healthy volunteers (median, 6%; interquartile range, 5.6%-6.3%). These quantitative results confirm what is visually observed on the (3)He images. A Spearman correlation of r = -0.82 was found between the change in whole-lung defect percentage and the number of days between final treatment and second (3)He imaging. CONCLUSION: Regional quantification of lung ventilation is indeed feasible and may be a useful technique for image-guided treatment of obstructive lung diseases, such as bronchial thermoplasty for severe asthma. In these patients, ventilation defects decreased as a function of time after treatment.
Authors: T A Altes; P L Powers; J Knight-Scott; G Rakes; T A Platts-Mills; E E de Lange; B A Alford; J P Mugler; J R Brookeman Journal: J Magn Reson Imaging Date: 2001-03 Impact factor: 4.813
Authors: Harald E Möller; X Josette Chen; Brian Saam; Klaus D Hagspiel; G Allan Johnson; Talissa A Altes; Eduard E de Lange; Hans-Ulrich Kauczor Journal: Magn Reson Med Date: 2002-06 Impact factor: 4.668
Authors: Stanislao Fichele; Neil Woodhouse; Andrew J Swift; Zead Said; Martyn N J Paley; Larry Kasuboski; Gary H Mills; Edwin J R van Beek; Jim M Wild Journal: J Magn Reson Imaging Date: 2004-08 Impact factor: 4.813
Authors: Gerard Cox; John D Miller; Annette McWilliams; J Mark Fitzgerald; Stephen Lam Journal: Am J Respir Crit Care Med Date: 2006-02-02 Impact factor: 21.405
Authors: Robert V Cadman; Robert F Lemanske; Michael D Evans; Daniel J Jackson; James E Gern; Ronald L Sorkness; Sean B Fain Journal: J Allergy Clin Immunol Date: 2012-12-11 Impact factor: 10.793
Authors: Ashley Busacker; John D Newell; Thomas Keefe; Eric A Hoffman; Janice Cook Granroth; Mario Castro; Sean Fain; Sally Wenzel Journal: Chest Date: 2008-08-08 Impact factor: 9.410
Authors: Jürgen Biederer; Marcus Both; Joachim Graessner; Carsten Liess; Peter Jakob; Michael Reuter; Martin Heller Journal: Radiology Date: 2003-01 Impact factor: 11.105
Authors: Mario Castro; Adalberto S Rubin; Michel Laviolette; Jussara Fiterman; Marina De Andrade Lima; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; David R Duhamel; Charlene McEvoy; Richard Barbers; Nicolaas H T Ten Hacken; Michael E Wechsler; Mark Holmes; Martin J Phillips; Serpil Erzurum; William Lunn; Elliot Israel; Nizar Jarjour; Monica Kraft; Narinder S Shargill; John Quiring; Scott M Berry; Gerard Cox Journal: Am J Respir Crit Care Med Date: 2009-10-08 Impact factor: 21.405
Authors: Edward Y Lee; Yanping Sun; David Zurakowski; Hiroto Hatabu; Umakanth Khatwa; Mitchell S Albert Journal: J Thorac Imaging Date: 2009-05 Impact factor: 3.000
Authors: Rob H Ireland; Neil Woodhouse; Nigel Hoggard; James A Swinscoe; Bernadette H Foran; Matthew Q Hatton; Jim M Wild Journal: Phys Med Biol Date: 2008-10-09 Impact factor: 3.609
Authors: Fumin Guo; Dante Capaldi; Miranda Kirby; Khadija Sheikh; Sarah Svenningsen; David G McCormack; Aaron Fenster; Grace Parraga Journal: J Med Imaging (Bellingham) Date: 2018-06-28
Authors: Marcus J Couch; Robert Thomen; Nikhil Kanhere; Raymond Hu; Felix Ratjen; Jason Woods; Giles Santyr Journal: J Cyst Fibros Date: 2019-03-25 Impact factor: 5.482
Authors: Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland Journal: Pediatr Radiol Date: 2016-08-05
Authors: Abhaya Trivedi; Chase Hall; Eric A Hoffman; Jason C Woods; David S Gierada; Mario Castro Journal: J Allergy Clin Immunol Date: 2017-01 Impact factor: 10.793
Authors: Robert P Thomen; Laura L Walkup; David J Roach; Nara Higano; Andrew Schapiro; Alan Brody; John P Clancy; Zackary I Cleveland; Jason C Woods Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Robert P Thomen; Laura L Walkup; David J Roach; Zackary I Cleveland; John P Clancy; Jason C Woods Journal: J Cyst Fibros Date: 2016-07-29 Impact factor: 5.482
Authors: Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods Journal: Eur Respir J Date: 2019-05-02 Impact factor: 16.671